Evaluation of ten (10) SARS-CoV-2 rapid serological tests in comparison with WANTAI SARS-CoV-2 ab ELISA in Burkina Faso, West Africa
Open Access
- 30 March 2023
- journal article
- research article
- Published by Springer Nature in Virology Journal
- Vol. 20 (1) , 1-9
Abstract
Background: The aim of this study was to evaluate the performance of ten (10) SARS-CoV-2 serological rapid diagnostic tests in comparison with the WANTAI SARS-CoV-2 Ab ELISA test in a laboratory setting. Materials and methods: Ten (10) SARS-CoV-2 serological rapid diagnostic tests (RDTs) for SARS-CoV-2 IgG/IgM were evaluated with two (2) groups of plasma tested positive for one and negative for the other with the WANTAI SARS-CoV-2 Ab ELISA. The diagnostic performance of the SARS-CoV-2 serological RDTs and their agreement with the reference test were calculated with their 95% confidence intervals. Results: The sensitivity of serological RDTs ranged from 27.39 to 61.67% and the specificity from 93.33 to 100% compared to WANTAI SARS-CoV-2 Ab ELISA test. Of all the tests, two tests (STANDARD Q COVID-19 IgM/IgG Combo SD BIOSENSOR and COVID-19 IgG/IgM Rapid Test (Zhejiang Orient Gene Biotech Co., Ltd)) had a sensitivity greater than 50%. In addition, all ten tests had specificity greater than or equal to 93.33% each. The concordance between RDTs and WANTAI SARS-CoV-2 Ab ELISA test ranged from 0.25 to 0.61. Conclusion: The SARS-CoV-2 serological RDTs evaluated show low and variable sensitivities compared to the WANTAI SARS-CoV-2 Ab ELISA test, with however a good specificity. These finding may have implications for the interpretation and comparison of COVID-19 seroprevalence studies depending on the type of test used.Keywords
This publication has 26 references indexed in Scilit:
- Differences of SARS-CoV-2 serological test performance between hospitalized and outpatient COVID-19 casesClinica Chimica Acta, 2020
- Current methods for diagnosis of human coronaviruses: pros and consAnalytical and Bioanalytical Chemistry, 2020
- Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence SettingThe Journal of Infectious Diseases, 2020
- A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 AntibodiesThe Journal of Applied Laboratory Medicine, 2020
- Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysisBMJ, 2020
- Antibody tests for identification of current and past infection with SARS-CoV-2Cochrane Database of Systematic Reviews, 2020
- Evaluation of serological tests for SARS-CoV-2: Implications for serology testing in a low-prevalence settingmedRxiv, 2020
- Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020Clinica Chimica Acta, 2020
- A specifikus IgM- és IgG-antitesteket detektáló gyorstesztek értéke a SARS CoV-2 vírusfertőzés kimutatásában (A COVID–19-pandémia orvosszakmai kérdései)Orvosi Hetilap, 2020
- The Measurement of Observer Agreement for Categorical DataBiometrics, 1977